iRadimed, which makes non-magnetic MRI-safe IV infusion pumps, raised $13 million by offering 2.0 million shares at $6.25, above the $5 to $6 range. iRadimed will list on the NASDAQ under the symbol IRMD. Roth Capital acted as sole bookrunner on the deal.
